| 27-Aug-2008 | S | Jyothy Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 27, 2008, has approved sub-division of existing Equity shares of Rs 5/- each into 5 equity shares of Rs 1/- each. Sub-division of Equity Shares is subject to approval of shareholders.
Jyothy Laboratories Ltd has informed BSE that the members at the Annual General Meeting (AGM) of the Company held on November 11, 2008, inter alia, have accorded the following:
1.Authorized Share Capital of the Company and existing equity shares of Rs 5 each was sub-divided into 5 (five) equity shares of Rs 1 each.
2. Pursuant to passing of Resolution as per item (6) above, Clause V of Memorandum of Association and Article 1.1 and 3 of Articles of Association of the Company were amended to give effect of sub-division of equity shares from Rs 5 to Re 1 per share.
(As Per BSE Announcement Website dated on 11.11.2008)
SUB. :- Sub Division of equity shares of Jyothy Laboratories Limited (Scrip Code 532926)
Trading members of the Exchange are hereby informed that, Jyothy Laboratories Limited has fixed the Record Date for the purpose of sub division of equity shares of the company.
COMPANY NAME CODE
Jyothy Laboratories Limited
(532926)
RECORD DATE
19/12/2008
PURPOSE
Sub Division of existing equity shares from every ONE equity share of Rs.5/- each into FIVE equity shares of Re.1/- each.
SUB-DIVIDED PAID-UP VALUE
Re.1/-
SUB-DIVIDED PAID-UP VALUE W.E.F.
12/12/2008 DR-175/2008 - 2009
The auction in the equity shares of Jyothy Laboratories Limited in Dematerialised Securities - Rolling Settlement Segment on 12/12/2008, 15/12/2008 and 16/12/2008 will be conducted as per face value of Rs.5/- each. Trading members are, therefore, requested to take abundant precautions while mentioning the rates for offering the equity shares of the said company in auction on the said dates.
The scrip will be in No Delivery from 12/12/2008 (DR-175/2008-2009) to 18/12/2008 (DR-179/2008-2009).
Note :-
i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Re.1/- paid up w.e.f. 12/12/2008.
ii. ISIN No. INE668F01023 of Rs.5/- paid up will not be valid for transactions done on the Exchange on or after 12/12/2008, except for the auction transactions, which will be conducted on 12/12/2008, 15/12/2008 and 16/12/2008 respectively.
iii. The new ISIN Number for Re.1/- paid up will be informed to the market by a separate notice.
(As Per BSE Notice Dated on 24.11.2008) | 19-Dec-2008 | |
| 03-May-2023 | D | Outcome of the Board Meeting held on May 3, 2023
Recommended a Dividend of Rs. 3/- (Rupees Three only) per equity share of Re.1/- each
for the financial year 2022-23, which if approved by the shareholders of the Company at
the ensuing Annual General Meeting, will be paid/ dispatched on or after July 27, 2023;
Book Closure And Record Date For 32nd Annual General Meeting & Final Dividend 2022-23
The Register of Member and Share Transfer Books of the Company will remain closed from Tuesday, July 4, 2023 to Tuesday, July 11, 2023 (both days inclusive) for taking record of the members of the Company who are eligible for the purpose of payment of dividend and for the 32nd Annual General Meeting of the Company
Intimation of Book closure and record date for the purpose of payment of dividend and for the 32nd Annual General Meeting of the Company
(As Per BSE Announcement Dated on 05.05.2023) | 03-Jul-2023 | |
| 24-May-2022 | D | Equity Rs.2.5000 per share(250%)Final Dividend | 01-Jul-2022 | |
| 18-May-2021 | D | The Board of Directors at its Meeting held today recommended a Dividend of Rs. 4.00/- (Rupees Four only) per equity share of Re.1/- each for the financial year 2020-21 and fixed the date of 30th Annual General Meeting of the Company as Friday, July 30, 2021. | 20-Jul-2021 | |
| 12-Mar-2020 | D | The Board approved an Interim Dividend of Rs. 3/- (Rupees Three only) per equity share of Re. 1/- each for the Financial Year 2019-20. The Interim Dividend for the Financial Year 2019-20 shall be paid on or after March 24, 2020. | 19-Mar-2020 | |
| 07-May-2019 | D | Jyothy Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 07, 2019, inter alia, have:
Recommended a Dividend of Rs. 3/- (Rupees Three only) per equity share of Re.1/- each for the financial year 2018-19, which if approved by the shareholders at the ensuing Annual General Meeting, will be paid/ dispatched on or after July 29, 2019; | 12-Jul-2019 | |
| 16-May-2018 | D | Jyothy Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 16, 2018, inter alia, have recommended a Dividend of 50 Paise (Paise Fifty only) per equity share of Re. 1/- each for the financial year 2017-18 on the proposed expanded capital base (on account of Bonus Issue), which if approved by the shareholders at the ensuing Annual General Meeting, will be paid / dispatched on or after July 30, 2018. | 16-Jul-2018 | |
| 18-May-2017 | D | Jyothy Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 18, 2017, inter alia, have recommended Final Dividend of Rs. 6/- (Rupees Six Only) per equity share of Re. 1/- each for the financial year ended March 31, 2017, which if approved by the shareholders at the ensuing Annual General Meeting, will be paid / dispatched on or before July 15, 2017. | 03-Jul-2017 | |
| 23-May-2016 | D | Jyothy Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 23, 2016, inter alia, have:
1. Recommended Final Dividend of Re. 1/- (Rupee One Only) per equity share of Re. 1/- each for the financial year ended March 31, 2016, which if approved by the shareholders at the ensuing Annual General Meeting, will be paid/ dispatched on or before July 31, 2016; | 14-Jul-2016 | |
| 10-Mar-2016 | D | Jyothy Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 10, 2016, recommended Interim Dividend of Rs. 4.00 (Rupees Four Only) per equity share of Re. 1/- each for the financial year 2015-16.
The aforesaid dividend will be paid to the equity shareholders of the Company as on Record Date (i.e. March 18, 2016) and will be paid/ Dividend Warrant dispatched before March 31, 2016. | 17-Mar-2016 | |
| 25-May-2015 | D | Jyothy Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 25, 2015, inter alia, has recommended Final Dividend of Rs. 4.00 (Rupees Four only) per equity share of Re. 1/- each for the financial year ended March 31, 2015. The payment of dividend is subject to approval of shareholders at the enduing Annual General meeting. | 15-Jul-2015 | |
| 22-May-2014 | D | Jyothy Laboratories Limited has informed the Exchange that the Board of Directors of the
Company at its meeting held on May 22, 2014 has Recommended Final Dividend of Rs.2.00 (Rupees Two Only) per equity share of Re. 1/- each for the
financial year ended March 31, 2014. The payment of dividend is subject to approval of shareholders at the ensuing Annual General Meeting. | 31-Jul-2014 | |
| 28-Jan-2014 | D | Jyothy Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 28, 2014, inter alia, has approved the following:
1. Declaration of Interim Dividend @ Re.1/- (Rupee One Only) per equity share of Re. 1/- each for the financial year 2013-14. | 06-Feb-2014 | |
| 22-May-2013 | D | Jyothy Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 22, 2013, inter alia, has transacted the following:
1. Recommended Dividend of Rs. 2.50 (Rupees Two and Paise Fifty Only) per equity shares of Re. 1/- each for the financial year ended March 31, 2013. The payment of dividend is subject to approval of shareholders at the ensuing Annual General Meeting, | 25-Jul-2013 | |
| 22-May-2012 | D | Jyothy Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 23, 2012 inter alia, has transacted the following:
1. Recommended Dividend of Rs. 2.50 (Rupees Two and Paise Fifty Only) per equity shares of Re.1/- each for the financial year ended March 31, 2012. The payment of dividend is subject to approval of shareholders at the ensuing Annual General Meeting.
| 12-Jul-2012 | |
| 30-May-2011 | D | Jyothy Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2011, inter alia, has transacted the following business:
Recommended Dividend of Rs. 5/- per equity shares of Re. 1/- each for the financial year ended March 31, 2011. The payment of dividend is subject to approval of shareholders. | 08-Sep-2011 | |
| 25-May-2010 | D | Jyothy Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 25, 2010, inter alia, has recommended Dividend of Rs. 4/- per equity shares of Re. 1/- each for the financial year ended March 31, 2010. The payment of dividend is subject to approval of shareholders. | 15-Jul-2010 | |
| 05-Jun-2009 | D | Jyothy Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 05, 2009, inter alia, has transacted the following business:
1. Recommended Dividend of Rs 2/- per equity shares of Rs 1/- each for the financial year ended March 31, 2009. The payment of dividend is subject to approval of shareholders. | 16-Jul-2009 | |
| 27-Aug-2008 | D | Jyothy Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 27, 2008, has recommended Dividend of Rs 7.50 per equity shares of Rs 5/- each for the financial year ended June 30, 2008. | 29-Oct-2008 | |
| 27-Aug-2008 | D | Jyothy Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 27, 2008, has recommended a Special Silver Jubilee Year Dividend of Rs 2.50 per equity share. | 29-Oct-2008 | |
| 15-Jun-2018 | B | 1:1 Bonus Issue of Equity Shares
Trading Members of the Exchange are hereby informed that, Jyothy Laboratories Limited has fixed the record date for the purpose of Bonus Issue. The transactions in the equity shares of the company would be on an ex-bonus basis with effect from the under mentioned date.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
Jyothy Laboratories Limited
(532926, 632926)
RECORD DATE
30/06/2018
PURPOSE
Issue of 01 (One) Bonus equity share of Re.1/- each for every 01 (One) existing equity share of Re.1/- each held.
Ex-Bonus basis from Date & Sett. No.
28/06/2018 DR-065/2018-2019
Trading Members of the Exchange are note requested to take of it.
(As Per BSE Notice Dated on 26.06.2018) | 30-Jun-2018 | 1:1 |
| 04-Jul-2012 | B | SUB. :- Dividend payment and Bonus issue of Jyothy Laboratories Ltd. (Scrip Code: 532926)
Trading Members of the Exchange are hereby informed that, Jyothy Laboratories Ltd. has fixed
the Book Closure for the purpose of Dividend payment and Bonus Issue. The transactions in
the equity shares of the company should be on an ex- dividend and ex-bonus basis with effect
from the under mentioned date.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
Jyothy Laboratories Ltd.
(532926)
BOOK CLOSURE
16/07/2012 to 16/07/2012
PURPOSE
Dividend payment of Rs. 2.50/- per equity share
AND
Issue of 1 (ONE) Bonus equity share of Re. 1/- each for every 1 (ONE) existing equity share of Re. 1/- held.
Ex- Dividend and Ex-Bonus basis from Date & Sett. No.
12/07/2012 DR-074/2012-2013
Trading Members of the Exchange are requested to take note of it. | 16-Jul-2012 | 1:1 |
| 03-May-2024 | BC | Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2024 inter alia to consider and approve the Audited Financial Results of the Company on | 15-May-2024 | |
| 31-Jan-2024 | BC | Intimation under Regulation 30 read with Part A of Schedule IIII of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding changes in Directorship of the Company | 01-Apr-2024 | |
| 31-Mar-2024 | BC | Pursuant to Regulation 30(2) read with Para A of Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to i | 31-Mar-2024 | |
| 03-May-2023 | BC | Audited Financial Results for the quarter and year ended March 31, 2023
Re-appointment of Ms. Bhumika Batra as an Independent Director of the Company for a second consecutive term of 5 years comme | 14-Mar-2024 | |
| 06-Feb-2024 | BC | Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015- Dispatch of Postal Ballot Notice
Newspaper publication for dispatch of Postal Ballot Noti | 07-Mar-2024 | |